5:40 PM
 | 
Jun 13, 2014
 |  BC Extra  |  Politics & Policy

EU Ombudsman still concerned with transparency policy

EU Ombudsman Emily O'Reilly said she remained concerned with EMA's clinical data transparency policy despite an amendment proposed this week. O'Reilly said she welcomed the amendment proposed by EMA...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >